Filing Details
- Accession Number:
- 0001209191-12-042906
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-22 18:31:57
- Reporting Period:
- 2012-08-20
- Filing Date:
- 2012-08-22
- Accepted Time:
- 2012-08-22 18:31:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1243399 | Jr A Woodrow Myers | Myers Ventures Llc 1 North Illinois Street 2101 Indianapolis IN 91362 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-20 | 5,507 | $9.95 | 7,743 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-20 | 5,507 | $35.06 | 2,236 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-08-21 | 10,993 | $9.95 | 13,229 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-21 | 10,993 | $35.28 | 2,236 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (right to buy) | Disposition | 2012-08-20 | 5,507 | $0.00 | 5,507 | $9.95 |
Common Stock | Director Stock Option (right to buy) | Disposition | 2012-08-21 | 10,993 | $0.00 | 10,993 | $9.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
10,993 | 2016-04-11 | No | 4 | M | Direct | |
0 | 2016-04-11 | No | 4 | M | Direct |
Footnotes
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $35.00 to $35.21.
- Represents weighted average sale price. Actual sale prices ranged from $35.21 to $35.54.
- The option became exercisable as to 25% of the shares on April 11, 2007, and became exercisable as to 1/48th of the shares each full month thereafter.